WO2006011531A1 - 被検試料の自動判別方法 - Google Patents
被検試料の自動判別方法 Download PDFInfo
- Publication number
- WO2006011531A1 WO2006011531A1 PCT/JP2005/013767 JP2005013767W WO2006011531A1 WO 2006011531 A1 WO2006011531 A1 WO 2006011531A1 JP 2005013767 W JP2005013767 W JP 2005013767W WO 2006011531 A1 WO2006011531 A1 WO 2006011531A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- test sample
- chip
- light
- sample
- plasma
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/59—Transmissivity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00594—Quality control, including calibration or testing of components of the analyser
- G01N35/00603—Reinspection of samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
- G01N2035/1027—General features of the devices
- G01N2035/1048—General features of the devices using the transfer device for another function
- G01N2035/1062—General features of the devices using the transfer device for another function for testing the liquid while it is in the transfer device
Definitions
- the present invention provides a method for analyzing a test sample, that is, a method for analyzing a specific component contained in a test sample (for example, a biological fluid, particularly blood). On how to do.
- a test sample for example, a biological fluid, particularly blood.
- Patent Document 1 discloses a method in which whole blood is sonicated or mixed with a hypotonic solution to force hemolysis.
- Patent Document 2 discriminates whether or not a specimen contains blood cells, and contains blood cells in response to a discrimination result indicating that the specimen contains blood cells.
- the determination result indicating that only the measurement items that can be analyzed by the sample are selected, whether or not the force is determined, and only the measurement items that can be analyzed by the sample including blood cells are selected.
- An analytical method is disclosed.
- Patent Document 1 Japanese Patent Laid-Open No. 10-48214
- Patent Document 2 JP-A-6-265554
- An object of the present invention is to provide a general-purpose automatic analyzer capable of analyzing not only plasma or serum but also whole blood as a test sample.
- An object of the present invention is to provide a method capable of omitting the setting operation and automatically discriminating the type of the test sample.
- Another object of the present invention is to provide a method capable of detecting forgetting to put a test sample at the same time as determining the type of the test sample.
- Another object of the present invention is to provide a method capable of simultaneously detecting leakage of a dispensing tip in an automatic analyzer that is equipped with a dispensing tip.
- a test sample that may contain an analysis target substance is supplied to a reaction system by a supply means including a light transmission region made of a light transmitting material.
- the reagent for detecting the substance to be analyzed is reacted with the test sample, and a signal derived from the reaction product is analyzed.
- the light transmitting region in the supplying means is irradiated with light and the optical intensity thereof is analyzed, preferably the type of the test sample (preferably the test sample in the supplying means
- the supply means can mount a chip.
- a test sample that may contain an analyte is supplied to a reaction system by a dispensing means that is equipped with a chip and can suck and discharge a liquid through the chip (preferably a dispensing system).
- a dispensing means that is equipped with a chip and can suck and discharge a liquid through the chip (preferably a dispensing system).
- the reagent for detecting the substance to be analyzed is reacted with the test sample, and a signal derived from the reaction product is analyzed.
- the sample holding portion of the chip is irradiated with light and the optical intensity is analyzed, preferably the type of the test sample (preferably in the chip)
- the optical intensity is analyzed, preferably the type of the test sample (preferably in the chip)
- the type of Z or test sample more preferably, whether or not the chip is mounted, the presence or absence of the test sample in the chip, and the type of Z or test sample
- the supply means is a tube or a transfer channel. That is, according to the present invention, a test sample that may contain an analyte can be supplied to a reaction system by a tube or a transfer channel including a light transmission region made of a light transmissive material, and the analyte can be detected.
- the supply step that is, the test sample is placed in a tube or a transfer channel. In the state of passing through the light transmitting region, and irradiating the light transmitting region with light, and analyzing the optical intensity thereof (preferably the presence or absence of the test sample in the supply means) , And Z or the type of test sample).
- the test sample is whole blood, serum, or plasma.
- the present invention provides a test sample that may contain a substance to be analyzed by a supply means. Analyzing the substance to be analyzed, supplying the reaction system, reacting the reagent for detection of the substance to be analyzed with the sample to be analyzed, and analyzing the signal derived from the reaction product In the device
- a light irradiating means capable of irradiating light to the light transmitting region of the supplying means
- the discrimination means is, for example,
- Boundary value storage means derived from previously measured values
- an instruction means for instructing the subsequent reaction route or warning
- an output means for the comparison result warning means
- the supply means can mount a chip.
- a test sample that may contain an analyte is supplied to a reaction system by a dispensing means that is equipped with a chip and can suck and discharge a liquid through the chip (preferably a dispensing system).
- a dispensing means that is equipped with a chip and can suck and discharge a liquid through the chip (preferably a dispensing system).
- the analyzer for analysis target substance the reagent for detection of the analysis target substance is reacted with the test sample, and the signal derived from the reaction product is analyzed.
- Dispensing means that can be attached with a tip and can suck and discharge liquid via the tip
- a light irradiating means capable of irradiating light to a sample holding portion of the chip in the supplying step (that is, a state in which the test sample is sucked into the chip);
- test sample preferably the presence or absence of the test sample in the chip, and the type of Z or test sample, more preferably whether or not the chip is mounted
- Discriminating means for discriminating the presence or absence of the test sample and the type of Z or test sample
- the supply means is a tube or a transfer channel. That is, according to the present invention, a test sample that may contain a substance to be analyzed is supplied to a reaction system by a tube or a transfer channel including a light transmission region made of a light transmissive material.
- the analyzer for analyzing an analyte the reagent for detecting the analyte is reacted with the sample to be analyzed, and a signal derived from the reaction product is analyzed.
- a light irradiating means capable of irradiating light to the light transmitting region of the tube or the transfer channel
- a discriminating means for discriminating the type of the test sample preferably the presence or absence of the test sample in the tube or the transfer channel, and the type of Z or the test sample) by the optical intensity.
- the test sample is whole blood, serum, or plasma.
- the operator can omit the operation of inputting or setting the type of the test sample in the analyzer in advance. For example, it is particularly useful for a practitioner who does not have a dedicated device such as a centrifuge, or for an emergency examination that does not have time. In addition, for example, it is possible to detect forgetting to put a test sample only by judging the type of the test sample. In addition, in the type of automatic analyzer equipped with dispensing tips, it is possible to simultaneously detect omission of dispensing tips. it can.
- FIG. 1 is a front view (A) and a side view (B) schematically showing an embodiment of an automatic analyzer to which the discrimination method of the present invention can be applied.
- FIG. 2 is an explanatory view schematically showing an execution procedure of one embodiment of an automatic analysis method to which the discrimination method of the present invention can be applied.
- FIG. 3 is an explanatory view schematically showing one embodiment of an optical analysis system that can be used in the present invention.
- FIG. 4 is an enlarged partial front view (A) and an enlarged partial side view (B) schematically showing a state in which an aspect of an optical analysis system that can be used in the present invention is incorporated in an automatic analyzer. .
- the discriminating method of the present invention can be arbitrarily applied as long as it is a method including a step of supplying a test sample to a reaction system among automatic analysis methods of a test sample (for example, biological fluid, particularly blood). can do.
- an automatic analysis method including a step of supplying a test sample to a reaction system (for example, dispensing) by a dispensing means that can be mounted with a chip and can suck and discharge a liquid through the chip, or Automatic including a step of supplying the test sample to the reaction system by a transfer means (for example, a tube or a transfer channel) capable of inhaling the test sample from one end and discharging the test sample from the other end. It can be applied to analysis methods.
- the analysis apparatus of the present invention can be arbitrarily applied as long as it is an apparatus provided with supply means for supplying a test sample to a reaction system among automatic analysis apparatuses.
- a device that can be equipped with a tip and has dispensing means capable of sucking and discharging liquid through the tip, or a test sample is sucked from one end and the test sample is sucked from the other end
- the present invention can be applied to an apparatus provided with a transfer means (for example, a tube or a transfer channel) that can discharge the gas.
- a transfer means for example, a tube or a transfer channel
- the automatic analyzer 1 shown in FIG. 1 includes a measurement table 2 on which a cartridge 3 having a plurality of wells capable of dispensing a test sample and Z or detection reagents can be arranged.
- a plurality of nozzles 5 on which a chip 4 can be mounted and capable of sucking and discharging a liquid through the chip are arranged in a row.
- the nozzle 5 can move up and down in the vertical direction.
- a predetermined well can be arranged directly under the nozzle.
- a magnet capable of contacting the outer side wall of the chip 4 can be arranged, and in this case, magnetic particles (for example, specific to the analyte compound to be analyzed) can be arranged. BZF separation can be performed in the chip by using in combination with magnetic particles coated with the antibody on the surface.
- the tip portion and the nozzle portion are integrated.
- a suction Z discharge means or a transfer means capable of sucking a test sample on one end and discharging the test sample from the other end can be used.
- the transfer means include a tube (for example, a flexible tube or a capillary tube), a transfer channel, and the like.
- FIG. 2 An example of an automatic analysis method using the automatic analyzer shown in FIG. 1 is shown in FIG.
- the automatic analysis method shown in Fig. 2 uses magnetic particles coated with the first antibody, enzyme-labeled second antibody, and luminescent substrate as detection reagents, and a magnet that can contact the outer wall of the chip. In other words, BZF separation is performed in the chip.
- a predetermined amount of test sample is added to the first well in which a predetermined amount of antibody-coated magnetic particles has been dispensed in advance via a tip, and suction and discharge are performed. repeat As a result, the test sample and the antibody-coated magnetic particles are sufficiently mixed and then incubated.
- the reaction solution is sucked into the chip, and the reaction solution is discharged with the magnetic particles captured on the inner wall of the chip by a magnet.
- the magnetic particles captured by the magnet are cleaned by inserting the tip into the second well where a predetermined amount of cleaning liquid has been dispensed in advance and repeating the suction and discharge of the cleaning liquid. To do.
- the tip is inserted into the third well in which a predetermined amount of enzyme-labeled antibody solution has been dispensed in advance, and the suction and discharge of the labeled antibody solution are repeated sufficiently. Incubate after mixing. When the antigen-antibody reaction has sufficiently progressed, the reaction solution is sucked into the chip, and the reaction solution is discharged while the magnetic particles are captured on the inner wall of the chip by a magnet.
- the magnetic particles captured by the magnet are cleaned by inserting the tip into the fourth well where a predetermined amount of cleaning liquid has been dispensed in advance and repeating the suction and discharge of the cleaning liquid. To do.
- the luminescence reaction is carried out by inserting the tip into the fifth wall where a predetermined amount of the luminescence substrate solution has been dispensed in advance and repeating the suction and discharge of the substrate solution. To do. After reacting for a predetermined time, the amount or concentration of the analyte can be determined by measuring the amount of luminescence.
- test sample used in the present invention examples include a biological fluid, and in particular, blood such as whole blood, serum, or plasma.
- the substance to be analyzed contained in the test sample is not particularly limited as long as a substance that specifically binds to the analyte and forms a reaction product is present.
- the combination of a substance to be analyzed and a substance that specifically binds thereto includes, for example, an antigen and an antibody, an antibody and an antigen, a protein and a ligand, a sugar chain and a lectin, and particularly preferably an antigen and an antibody. Or an antibody and an antigen.
- “specifically binds” means to bind specifically biochemically to form a reaction product.
- analytes include hepatitis B virus surface antigen (HBsAg), hepatitis C virus (HCV) antibody and antigen, human immunodeficiency virus (HIV) antibody, human T cell leukemia Examples include IL-1 (HTLV-1) antibody and syphilis treponema (TP) antibody.
- HBV hepatitis B virus surface antigen
- HCV hepatitis C virus
- HSV human immunodeficiency virus
- HTLV-1 human T cell leukemia
- TP syphilis treponema
- myocardial markers creatine kinase MB (CKMB), myoglobin, troponin
- various hormones, serum proteins and the like can be mentioned.
- the reaction system for measuring the test substance is not particularly limited.
- an immunological measurement method using an antigen-antibody reaction is preferably applied.
- an optical technique is used as a determination means.
- the sample holding part of the chip is irradiated with light, and the optical intensity is analyzed to determine whether the chip is mounted and whether there is a test sample in the chip. , And Z or the type of test sample can be discriminated.
- a tip for sucking a sample to be examined is preferably irradiated with light before and after the suction to a portion where the sample is held, and optically (for example, transmission, reflection, scattering).
- optically for example, transmission, reflection, scattering
- the light transmission region is irradiated with light and transferred through the tube or the transfer channel.
- the presence or absence of the test sample and the type of Z or test sample can be determined by analyzing the optical intensity that varies depending on the presence or absence of the test sample and Z or test sample type. .
- a state in which no chip is mounted hereinafter referred to as a chip not mounted state
- a state in which a chip is mounted however, in the chip In the state where the test sample is not inhaled (hereinafter referred to as the chip mounted state)
- the presence or absence of the chip is determined based on the amount of transmitted light in the non-chip mounted state compared to the chip mounted state. Can do.
- the amount of transmitted light is further reduced as compared with the state where the chip is mounted.
- plasma or serum aspirated state when plasma or serum is aspirated into the chip (hereinafter referred to as plasma or serum aspirated state), the amount of transmitted light is larger than that of the chip mounted state due to the lens effect of the chip. None exceed.
- Chip non-attachment state Plasma or serum aspiration state> Chip attachment state> Whole blood aspiration state, with the amount of transmitted light as an indicator, whether or not the chip is attached, the presence or absence of the test sample in the chip, and the type of Z or test sample Can be determined.
- the chip is not attached, for example, it is possible to detect an abnormality such as forgetting to install the chip or a mistake in attaching the chip.
- the chip is attached, for example, it is possible to detect forgetting to install the sample to be tested or an abnormality in installation leakage.
- the threshold value for each state varies depending on various conditions, for example, the type of optical analysis system to be used, chip characteristics (for example, material, material, chip shape, chip size, etc.), and so on. Although it cannot be defined, a person skilled in the art can easily determine the threshold value by measuring the amount of transmitted light in each state in advance according to a preliminary experiment, for example, the procedure of Examples 1-2 described later. .
- Plasma or serum suction state > Chip wearing state> Whole blood suction state
- threshold a the threshold between the plasma or serum aspiration state and the chip attachment state
- threshold value b the threshold between the tip attachment state and the whole blood aspiration state
- the chip is irradiated with light, and the transmitted light amount (hereinafter referred to as transmitted light amount T) is measured. If the transmitted light amount T of the unknown sample is larger than the threshold value a, it can be determined that the plasma or serum is aspirated, that is, the unknown sample is plasma or serum. If the transmitted light amount T of the unknown sample is smaller than the threshold value b, it can be determined that the plasma or serum is aspirated, that is, the unknown sample is plasma or serum. Transmission of unknown sample When the light amount T is a value between the threshold value a and the threshold value b, it can be determined that there is an abnormality.
- the determination logic used in the present invention (hereinafter sometimes referred to as a one-step method) is, for example,
- the optical intensity (for example, transmitted light amount) measured in the supplying step [for example, a state in which the sample to be discriminated is sucked into the supplying means (for example, a chip)] is determined using a predetermined threshold a (that is, the supplying means).
- a that is, the supplying means.
- the threshold b i.e., sucking the sample into the supply means I
- test sample is a hemolyzed sample or a normal chyle sample (that is, a cloudy sample having a high lipid content)
- a hemolyzed sample or a normal chyle sample that is, a cloudy sample having a high lipid content
- the amount of lipid contained is extremely high.
- the amount of transmitted light is a value between the threshold value a and the threshold value b (that is, there is an abnormality) in the discrimination logic, or the threshold value b.
- the test sample is diluted (for example, 1.2 times to 10 times, preferably 1.5 to 5 times, especially 2 times), and then measuring the amount of transmitted light again, it is possible to discriminate between chyle plasma or serum and whole blood . That is, there is almost no change between diluted blood before and after dilution, whereas the amount of transmitted light increases in chyle plasma or serum, so it is possible to distinguish between chyle plasma or serum and whole blood. Is possible. [0031] For example, if the discrimination logic described above is!
- transmitted light amount T ′ the transmitted light amount
- threshold value c in advance for the difference ( ⁇ '- ⁇ ) between the amount of transmitted light after dilution ( ⁇ ') and the amount of transmitted light ( ⁇ ) before dilution (stock solution)
- the transmitted light quantity ⁇ of the unknown sample is between the threshold value a and the threshold value b in the discrimination logic described above (in the normal sample, the sample is loaded on the chip). After the sample is diluted, the unknown sample is diluted, and after that, the amount of transmitted light T ′ is measured again under the same conditions.
- the unknown sample is chyle plasma or serum, the amount of transmitted light after dilution increases, whereas when the unknown sample is not sucked into the chip, the amount of transmitted light after dilution is almost unchanged. There is no.
- the threshold value d in advance for the difference ( ⁇ '- ⁇ ) between the transmitted light amount after dilution ( ⁇ ') and the transmitted light amount (T) before dilution (stock solution), " ⁇ '- ⁇ '' Is greater than the threshold d, the unknown sample can be determined to be chyle plasma or serum, and when ⁇ ′ ⁇ is less than or equal to the threshold d, the sample is not sucked into the chip. Can be judged.
- the discrimination logic used in the present invention (hereinafter sometimes referred to as a two-stage method) is, for example,
- the optical intensity (for example, transmitted light amount) T measured in the state in which the sample to be discriminated is sucked into the supplying means is set to a predetermined threshold a (that is, The threshold between the optical intensity when the plasma or serum is sucked into the supply means and the optical intensity when the sample is not sucked into the supply means) and the threshold b (i.e., the sample in the supply means)
- a that is, The threshold between the optical intensity when the plasma or serum is sucked into the supply means and the optical intensity when the sample is not sucked into the supply means
- the threshold b i.e., the sample in the supply means
- step (C) When the optical intensity of the discrimination target sample is larger than the threshold value a, Is smaller than the threshold value b, the implementation of the following step (C) is selected. If the value is between the threshold value a and the threshold value b, the following steps are performed. A step of selecting execution of (D),
- the difference between the optical intensity T ′ measured under the same conditions and the optical intensity T ( ⁇ ′— ⁇ ) is determined by a predetermined threshold c (that is, the sample is milky)
- a predetermined threshold c that is, the sample is milky
- the threshold between “ ⁇ , — ⁇ ” for plasma or serum and “ ⁇ , — ⁇ ” when the sample is whole blood is compared, and “ ⁇ '— ⁇ ” is the threshold c.
- the sample is chyle plasma or serum, and when “ ⁇ ′ ⁇ ” is less than or equal to the threshold c, the sample is judged to be whole blood; and
- the difference between the optical intensity T ′ measured under the same conditions and the optical intensity ⁇ ( ⁇ ′ ⁇ ) is determined by a predetermined threshold d (that is, the sample is milky) Compare the threshold between “ ⁇ ' ⁇ ” for plasma or serum and “ ⁇ ' ⁇ ” when the sample is not aspirated to the supply means. Is greater than the threshold value d, the sample is aspirated into the supply means and the sample is aspirated (eg, abnormal). Step to determine
- Table 1 shows the discrimination logic of the two-step method.
- the one-step method or the two-step method can be appropriately selected and carried out according to the state of the test sample group (sample set) to be discriminated. For example, if the test sample group does not contain chyle specimens with significantly higher lipid content, it is preferable to use the one-step method. The presence or absence of a chyle sample can be judged visually, for example. With the one-step method, the determination process is a single step, so simple and quick analysis is possible. Noh. On the other hand, if the test sample group contains, or may contain, a chyle sample with a significantly high lipid content, it is preferable to use the two-step method. The two-stage method allows more accurate analysis and does not require visual judgment.
- FIGS. 1-10 One embodiment of an optical analysis system (transmitted light system) that can be used in the present invention is shown in FIGS.
- a light emitting diode (LED) 11 and a photodiode (PD) 12 are arranged to face each other with the chip 4 interposed therebetween.
- the chip for example, a material that transmits light can be selected, and a light-transmitting plastic such as polyethylene, polystyrene, polycarbonate, polyacryl, or polypropylene can be used.
- the optical system may be optimized according to the emission intensity of the light source, the optical path diameter, etc., depending on the inner diameter, wall thickness, material, etc. of the chip.
- the irradiation site is preferably 2 to 10 mm in outer diameter, more preferably 3 to 6 mm, preferably 1 to 8 mm in inner diameter, more preferably 2 to 4 mm, preferably wall thickness 0. 2 to 2 mm, more preferably 0.5 to Lmm.
- the present invention is not limited to this value.
- the wavelength of the light-emitting diode may be any wavelength as long as it can optically distinguish at least the chip non-wearing state, the plasma or serum sucking state, the chip wearing state, and the whole blood sucking state.
- the wavelength of the emitted light currently varies from the ultraviolet part, the visible part, and the infrared part, and the medium power can be selected as appropriate.
- a visible part of 380 to 780 nm can be preferably used. More specifically, 400 to 700 nm is preferable, and 470 to 635 nm is preferably used.
- the present invention is not limited to this wavelength region.
- the means for detecting transmitted light can be changed as appropriate by using a known technique.
- the light output from the light source (light emitting diode) 11 passes through the chip, the light amount (current value) detected by the light receiver (photodiode) 12 is converted into current-voltage by the operational amplifier 13, and AD conversion 14 is used.
- the analog quantity is digitalized and processed by software.
- the digital numerical level of the specimen type and the presence / absence of the chip may be set in advance as a threshold value.
- an image processing method using a CCD camera can be used as the optical analysis system.
- an image processing method using a CCD camera when the received light is passed through an RGB primary color filter, it can be captured as color information, and the specimen can be identified and processed by color. Whether or not the RGB primary color filter is! / Can be judged by the density of black and white.
- light-emitting diodes for light sources: light-emitting diodes with a peak wavelength of 635 nm (GL3HD44; Stanley), light-emitting diodes with a peak wavelength of 573 nm (NSPY800AS; NICHIA), and light-emitting diodes with a peak wavelength of 470 nm (NSPB500S; NIC HIA) was used.
- PD photodiode
- S6775 Hamamatsu Photonicus
- the chip was made of polypropylene with an outer diameter of 3.6 mm, an inner diameter of 2.2 mm, and a thickness of 0.7 mm where the light was irradiated.
- Example 2 the same procedure as in Example 1 was performed, except that a light-emitting diode having a peak wavelength of 590 nm (EFY3863; Stanley) was used as the light-emitting diode for the light source.
- a light-emitting diode having a peak wavelength of 590 nm (EFY3863; Stanley) was used as the light-emitting diode for the light source.
- Bilirubin added 2 5 mg Z d 1.9 2
- Bilirubin added 7 5 mg Z d 1.9 3
- the samples used were Intra-Fat (20%, Takeda Pharmaceutical) and the concentrations shown in Table 4 Each sample and whole blood prepared in (Material) was used.
- the present invention can be applied to an application of automatic analysis of a test sample, for example, a biological fluid.
- a test sample for example, a biological fluid.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Quality & Reliability (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05767461.6A EP1775574B1 (en) | 2004-07-27 | 2005-07-27 | Method for automatic determination of sample |
ES05767461.6T ES2665788T3 (es) | 2004-07-27 | 2005-07-27 | Procedimiento de determinación automática de una muestra |
US11/572,749 US20080096285A1 (en) | 2004-07-27 | 2005-07-27 | Method for Automatic Determination of Sample |
JP2006527832A JP4452277B2 (ja) | 2004-07-27 | 2005-07-27 | 被検試料の自動判別方法 |
US13/323,561 US8557599B2 (en) | 2004-07-27 | 2011-12-12 | Method for automatic determination of sample |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-218142 | 2004-07-27 | ||
JP2004218142 | 2004-07-27 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/572,749 A-371-Of-International US20080096285A1 (en) | 2004-07-27 | 2005-07-27 | Method for Automatic Determination of Sample |
US13/323,561 Continuation US8557599B2 (en) | 2004-07-27 | 2011-12-12 | Method for automatic determination of sample |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006011531A1 true WO2006011531A1 (ja) | 2006-02-02 |
Family
ID=35786281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/013767 WO2006011531A1 (ja) | 2004-07-27 | 2005-07-27 | 被検試料の自動判別方法 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20080096285A1 (ja) |
EP (1) | EP1775574B1 (ja) |
JP (1) | JP4452277B2 (ja) |
CN (2) | CN102539737A (ja) |
ES (1) | ES2665788T3 (ja) |
WO (1) | WO2006011531A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008026670A1 (fr) * | 2006-08-30 | 2008-03-06 | Universal Bio Research Co., Ltd. | Séparateur de microplaque et procédé de séparation de microplaque |
JP2011519028A (ja) * | 2008-04-24 | 2011-06-30 | バイオメリオ・ベー・ベー | ピペット先端部内の流体を確認する方法および装置 |
WO2011099287A1 (ja) * | 2010-02-09 | 2011-08-18 | 株式会社マイクロジェット | 粒状体を含む液状体の吐出装置 |
JP2013072806A (ja) * | 2011-09-28 | 2013-04-22 | Aoi Seiki Kk | 検査前処理装置、検査前処理方法、及び検体処理装置 |
JP2013152215A (ja) * | 2012-01-25 | 2013-08-08 | F. Hoffmann-La Roche Ag | 液体試料中の分析物を検出する発光法及び分析システム |
JP2015515005A (ja) * | 2012-04-26 | 2015-05-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 自動分析計で流体試料中の被検体の量を測光法により決定するためのマルチアプリケーション法 |
WO2016121266A1 (ja) * | 2015-01-30 | 2016-08-04 | シャープ株式会社 | 試料分析装置及び試料分析方法 |
JP2017506342A (ja) * | 2014-02-19 | 2017-03-02 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 血漿試料を割り当てるための方法およびデバイス |
WO2023210384A1 (ja) * | 2022-04-28 | 2023-11-02 | 富士フイルム株式会社 | 検査装置 |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5511669B2 (ja) | 2007-10-02 | 2014-06-04 | セラノス, インコーポレイテッド | モジュール式ポイントオブケアデバイスおよびその使用 |
CN101915751B (zh) * | 2010-07-16 | 2014-03-05 | 常州亿晶光电科技有限公司 | 电池组件透光层透射率的模拟测试装置及其测试方法 |
CN106290159A (zh) | 2011-01-21 | 2017-01-04 | 提拉诺斯公司 | 样品使用最大化的系统和方法 |
US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
US8840838B2 (en) | 2011-09-25 | 2014-09-23 | Theranos, Inc. | Centrifuge configurations |
US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
CN102564956A (zh) * | 2011-12-31 | 2012-07-11 | 聚光科技(杭州)股份有限公司 | 一种近红外样品采集装置及方法 |
JP6085419B2 (ja) * | 2012-03-30 | 2017-02-22 | シスメックス株式会社 | 検体分析装置 |
US9500639B2 (en) * | 2012-07-18 | 2016-11-22 | Theranos, Inc. | Low-volume coagulation assay |
FR3009621B1 (fr) | 2013-08-09 | 2017-04-28 | Novacyt | Procede et appareil de preparation d'un contenant cellulaire comprenant des moyens de pre-analyse d'un echantillon preleve |
JP6567549B2 (ja) * | 2014-04-30 | 2019-08-28 | インストゥルメンテーション ラボラトリー カンパニー | 光学検出によるポイントオブケア凝固アッセイのための方法及びシステム |
US10837977B2 (en) * | 2015-05-11 | 2020-11-17 | Kabushiki Kaisha Yaskawa Denki | Rack for dispensing and dispensing system |
EP3408675B1 (en) | 2016-02-17 | 2021-03-31 | Becton, Dickinson and Company | Methods and automated modules for pre-analytical processing of biological samples for analysis |
CN207067156U (zh) | 2016-04-22 | 2018-03-02 | 贝克顿·迪金森公司 | 自动化诊断分析仪 |
WO2017184244A1 (en) | 2016-04-22 | 2017-10-26 | Becton. Dickinson And Company | Automated diagnostic analyzer and method for its operation |
CN110412659A (zh) * | 2018-04-27 | 2019-11-05 | 株式会社岛津制作所 | 一种判断是否有检测样品供给的判断方法 |
CN108614103A (zh) * | 2018-07-18 | 2018-10-02 | 武汉明德生物科技股份有限公司 | 化学发光检测方法及装置、化学发光免疫分析仪、存储介质 |
CN113167717A (zh) * | 2018-11-26 | 2021-07-23 | 国立研究开发法人物质材料研究机构 | 液体试样分析方法和装置 |
CN110132845A (zh) * | 2019-05-15 | 2019-08-16 | 浙江拱东医疗器械股份有限公司 | Cv值改善后的检测试剂条 |
CN110865104B (zh) * | 2019-11-28 | 2022-06-24 | 北京乐普诊断科技股份有限公司 | 一种血液样本类型识别检测系统 |
KR102360717B1 (ko) * | 2020-02-10 | 2022-02-10 | 주식회사 아이센스 | 반사형 포토센서를 이용한 전혈, 혈장 및 미흡입 자동구분방법 |
US11480565B2 (en) | 2020-06-12 | 2022-10-25 | Bio-Rad Laboratories, Inc. | Automated immunoassay |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0526876A (ja) * | 1991-07-24 | 1993-02-02 | Fuji Photo Film Co Ltd | 全血試料分析用乾式分析要素 |
JPH1019903A (ja) * | 1996-06-27 | 1998-01-23 | Aloka Co Ltd | 分注装置 |
JPH10274656A (ja) * | 1997-03-28 | 1998-10-13 | Kdk Corp | グルコース濃度の測定方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3861877A (en) * | 1974-01-21 | 1975-01-21 | Clinical Technology Inc | Optical analysis of fluids |
JPS5469497A (en) * | 1977-11-12 | 1979-06-04 | Kyoto Daiichi Kagaku Kk | Method and device for measuring blood solidification time |
US4303336A (en) * | 1978-08-28 | 1981-12-01 | Baxter Travenol Laboratories, Inc. | Method and apparatus for making a rapid measurement of the hematocrit of blood |
DE3175289D1 (en) * | 1980-05-30 | 1986-10-16 | Hitachi Ltd | Method for operating an apparatus for analysing samples optically |
US5114860A (en) * | 1984-10-09 | 1992-05-19 | Toa Medical Electronics Co., Ltd. | Device of measuring a blood coagulating time |
JPH06265554A (ja) | 1993-03-11 | 1994-09-22 | Daikin Ind Ltd | 血液生化学成分の分析方法およびその装置 |
JP3249919B2 (ja) | 1996-07-30 | 2002-01-28 | 株式会社堀場製作所 | 免疫測定方法 |
JP3239291B2 (ja) * | 1996-10-24 | 2001-12-17 | 三菱マテリアル株式会社 | 連続流れ分析法による複数成分の同時分析法とその装置 |
EP1054250B1 (en) * | 1999-01-25 | 2002-09-04 | Hamamatsu Photonics K.K. | Pipette adaptor, pipette for absorbance measurement, method and apparatus for absorbance measurement |
US20050101025A1 (en) * | 2003-11-12 | 2005-05-12 | Ho Winston Z. | Apparatus for proteins and nucleic acids analysis |
-
2005
- 2005-07-27 US US11/572,749 patent/US20080096285A1/en not_active Abandoned
- 2005-07-27 JP JP2006527832A patent/JP4452277B2/ja active Active
- 2005-07-27 WO PCT/JP2005/013767 patent/WO2006011531A1/ja active Application Filing
- 2005-07-27 EP EP05767461.6A patent/EP1775574B1/en active Active
- 2005-07-27 CN CN2011104239709A patent/CN102539737A/zh active Pending
- 2005-07-27 CN CNA2005800254774A patent/CN101010579A/zh active Pending
- 2005-07-27 ES ES05767461.6T patent/ES2665788T3/es active Active
-
2011
- 2011-12-12 US US13/323,561 patent/US8557599B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0526876A (ja) * | 1991-07-24 | 1993-02-02 | Fuji Photo Film Co Ltd | 全血試料分析用乾式分析要素 |
JPH1019903A (ja) * | 1996-06-27 | 1998-01-23 | Aloka Co Ltd | 分注装置 |
JPH10274656A (ja) * | 1997-03-28 | 1998-10-13 | Kdk Corp | グルコース濃度の測定方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1775574A4 * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008058103A (ja) * | 2006-08-30 | 2008-03-13 | Universal Bio Research Co Ltd | マイクロプレート分割処理装置およびマイクロプレート分割処理方法 |
US8921282B2 (en) | 2006-08-30 | 2014-12-30 | Universal Bio Research Co., Ltd. | Segmented process apparatus for microplate and segmented process method for microplate |
WO2008026670A1 (fr) * | 2006-08-30 | 2008-03-06 | Universal Bio Research Co., Ltd. | Séparateur de microplaque et procédé de séparation de microplaque |
JP2011519028A (ja) * | 2008-04-24 | 2011-06-30 | バイオメリオ・ベー・ベー | ピペット先端部内の流体を確認する方法および装置 |
KR101836375B1 (ko) | 2010-02-09 | 2018-03-08 | 가부시키가이샤 마이크로제트 | 입상체를 포함하는 액상체의 토출장치 |
WO2011099287A1 (ja) * | 2010-02-09 | 2011-08-18 | 株式会社マイクロジェット | 粒状体を含む液状体の吐出装置 |
JP5716213B2 (ja) * | 2010-02-09 | 2015-05-13 | 株式会社マイクロジェット | 粒状体を含む液状体の吐出装置 |
US10012665B2 (en) | 2010-02-09 | 2018-07-03 | Microjet Corporation | Discharge device for liquid material including particle-like bodies |
JP2013072806A (ja) * | 2011-09-28 | 2013-04-22 | Aoi Seiki Kk | 検査前処理装置、検査前処理方法、及び検体処理装置 |
US9261449B2 (en) | 2011-09-28 | 2016-02-16 | Aoi Seiki Co., Ltd. | Test preprocessing apparatus, test preprocessing method, and specimen processing apparatus |
JP2013152215A (ja) * | 2012-01-25 | 2013-08-08 | F. Hoffmann-La Roche Ag | 液体試料中の分析物を検出する発光法及び分析システム |
JP2015515005A (ja) * | 2012-04-26 | 2015-05-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 自動分析計で流体試料中の被検体の量を測光法により決定するためのマルチアプリケーション法 |
US10132805B2 (en) | 2012-04-26 | 2018-11-20 | Roche Diagnostics Operations, Inc. | Multi-application approach for photometric determination of an analyte in a fluid sample on an automated analyzer |
JP2017506342A (ja) * | 2014-02-19 | 2017-03-02 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 血漿試料を割り当てるための方法およびデバイス |
US10359416B2 (en) | 2014-02-19 | 2019-07-23 | Roche Diagnostics Operations, Inc. | Method and device for assigning a blood plasma sample |
JP2016142558A (ja) * | 2015-01-30 | 2016-08-08 | シャープ株式会社 | 試料分析装置及び試料分析方法 |
WO2016121266A1 (ja) * | 2015-01-30 | 2016-08-04 | シャープ株式会社 | 試料分析装置及び試料分析方法 |
WO2023210384A1 (ja) * | 2022-04-28 | 2023-11-02 | 富士フイルム株式会社 | 検査装置 |
Also Published As
Publication number | Publication date |
---|---|
US8557599B2 (en) | 2013-10-15 |
CN101010579A (zh) | 2007-08-01 |
JPWO2006011531A1 (ja) | 2008-05-01 |
US20120142043A1 (en) | 2012-06-07 |
CN102539737A (zh) | 2012-07-04 |
US20080096285A1 (en) | 2008-04-24 |
JP4452277B2 (ja) | 2010-04-21 |
EP1775574B1 (en) | 2018-03-14 |
EP1775574A1 (en) | 2007-04-18 |
EP1775574A4 (en) | 2012-02-29 |
ES2665788T3 (es) | 2018-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4452277B2 (ja) | 被検試料の自動判別方法 | |
US11693019B2 (en) | Automated liquid-phase immunoassay apparatus | |
EP2795339B1 (en) | Optical assay device with pneumatic sample actuation | |
TWI486570B (zh) | 使用濁度光散射技術以確保樣品妥適性之技術 | |
EP3394597B1 (en) | Optical detection of a substance in fluid | |
WO2013096822A2 (en) | Integrated test device for optical and electrochemical assays | |
JP2007501415A (ja) | プロセス監視用の装置及び方法 | |
WO2013096817A2 (en) | Integrated test device for optical detection of microarrays | |
JP2007501415A5 (ja) | ||
JP2010261953A (ja) | 試料の自動分析のためのシステムおよび方法 | |
JP5719768B2 (ja) | 生体関連物質測定用チューブおよび定量システム | |
JP2009109196A (ja) | 希釈倍率導出方法、定量方法、及び分析装置 | |
CN111512143A (zh) | 用于检测污染物存在或不存在的方法和传感器 | |
JPH08114600A (ja) | 生体試料分析システム | |
US20090254309A1 (en) | Abnormality identifying method, analyzing apparatus, and reagent | |
EP1857805A3 (en) | Apparatus for analyzing particles in urine and method thereof | |
WO2021145461A1 (ja) | 血液凝固測定装置、血液凝固時間の測定方法、血液凝固反応の完了判定方法、および血液自動遠心分離装置 | |
CN115244403A (zh) | 一种样本分析装置及方法 | |
JP4394940B2 (ja) | 便の検査方法及び検査装置 | |
US10684228B2 (en) | System and method of nephelometric determination of an analyte | |
JP2011017607A (ja) | 反応容器及びこの容器を用いた自動分析装置 | |
JP5160461B2 (ja) | 自動分析装置 | |
JP2024515175A (ja) | 複数の照明源を有する診断機器およびその方法 | |
KR20190114187A (ko) | 검사장치 및 검사장치의 제어방법 | |
KR20180077820A (ko) | 혈구 분석 장치 및 그의 검체 및 검체용기 감지방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006527832 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11572749 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580025477.4 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005767461 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005767461 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11572749 Country of ref document: US |